Cincor Pharma Inc (CINC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Operating Expenses | 22,244 | 21,353 | 13,704 | 25,233 | 7,690 |
| Operating Income | -22,244 | -21,353 | -13,704 | -25,233 | -7,690 |
| Other Income | 1,267 | 277 | -2,993 | -4,111 | -1,334 |
| Pre-tax Income | -20,978 | -21,075 | -16,697 | -29,344 | -9,024 |
| Net Income Continuous | -20,978 | -21,075 | -16,697 | -29,344 | -9,024 |
| Net Income | $-20,978 | $-21,075 | $-16,697 | $-29,344 | $-9,024 |
| EPS Basic Total Ops | -0.51 | -0.56 | -0.50 | -18.03 | -5.19 |
| EPS Basic Continuous Ops | -0.51 | -0.56 | -0.50 | -18.03 | -5.19 |
| EPS Diluted Total Ops | -0.51 | -0.56 | -0.50 | -18.03 | -5.19 |
| EPS Diluted Continuous Ops | -0.51 | -0.56 | -0.50 | -18.03 | -5.19 |
| EPS Diluted Before Non-Recurring Items | -0.51 | -0.56 | -0.50 | -15.71 | N/A |
| EBITDA(a) | $-22,494 | $-21,493 | $-13,741 | $-25,233 | $-7,690 |